Moscow, Russia

Lubov Sergeevna Vasilieva

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lubov Sergeevna Vasilieva. Retrieved from https://idiyas.com/inventor/lubov-sergeevna-vasilieva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lubov Sergeevna Vasilieva: Innovator in Cancer Treatment

Introduction

Lubov Sergeevna Vasilieva is a notable inventor based in Moscow, Russia. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on enhancing the efficacy of chemotherapy while minimizing its side effects.

Latest Patents

Vasilieva holds a patent for an ameliorant for chemical treatment of cancer. This invention, which comprises a chromanol glycoside, is designed to act safely and effectively in small dosages. It enhances the carcinostatic action of anti-cancer agents during chemotherapy and helps to repress the side effects associated with cancer treatments.

Career Highlights

Throughout her career, Vasilieva has worked with various organizations, contributing her expertise to advance cancer treatment methodologies. Her dedication to research has led to the development of innovative solutions that address critical challenges in chemotherapy.

Collaborations

Vasilieva has collaborated with notable individuals in her field, including Tsutomu Kagiya and Nina Petrovna Konovalova. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer treatment.

Conclusion

Lubov Sergeevna Vasilieva's contributions to cancer treatment through her innovative patent demonstrate her commitment to improving patient outcomes. Her work continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…